# Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

> **NCT05968846** · PHASE2 · COMPLETED · sponsor: **University of Tennessee Graduate School of Medicine** · enrollment: 19 (actual)

## Conditions studied

- Systemic Amyloidosis

## Interventions

- **DRUG:** Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)

## Key facts

- **NCT ID:** NCT05968846
- **Lead sponsor:** University of Tennessee Graduate School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05968846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05968846, "Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05968846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*